-
ReLife study abdominal CT scans
Abdominal CT scans are availabe for n=349 patients. -
UroLife study general questionnaire
Patients with non-muscle invasive bladder cancer (n=1512) completed paper-and-pencil or web-based questionnaires at 6 weeks (referring to pre-diagnosis lifestyle; n=1486) and 3... -
UroLife study blood samples
EDTA and heparin plasma samples were collected at 3 (n=1280) and 15 months (n=1122) after diagnosis. Heparin plasma samples have been analysed for carotenoids at 3 and 15 months... -
ReLife study genome-wide germline SNP data
Isolated DNA and genome-wide germline SNP data is available for n=333 patients. -
PRIDE Study saliva samples
Single saliva samples for cortisol analyses collected in 2012-2020 in subgroup (N~3400). Partially analyzed, remaining samples stored at -20°C. -
PRIDE Study blood samples
First trimester blood samples (plasma, serum, whole blood) of ~1000 PRIDE Study participants, available for genetic and biochemical analyses. Stored at -80°C. -
ReLife study blood samples
Serum and EDTA plasma samples were collected at 3 (n=335), 12 (n=266) and 24 months (n=237) after surgery. EDTA plasma samples have been analysed for CRP, IL-6, adiponectin, and... -
ReLife study accelerometer data
Accelerometer data (ActivPal) is available at 3 (n=346), 12 (n=323) and 24 months (n=271) after surgery. -
ReLife study food frequency questionnaire
A 163-item Food Frequency questionnaire was completed at 3 (n=352), 12 (n=330) and 24 months (n=275) after surgery. -
EATRIS-Plus multi-omics data of a human reference cohort
In this reference study, blood samples of 127 healthy individuals were analyzed with a wide range of -omics technologies. The profiling data set is publicly available. -
PRIDE Study obstetric records
Selected clinical data from obstetric records covering the pregnancy period and puerperium. Necessitates additional consent, provided by ~70% of participants -
PRISMA Questionnaire data
The extensive questionnaire covers a number of potential breast cancer risk predictors such as demographics, personal characteristics, reproductive characteristics, medication,... -
PRIDE Study pharmacy data
Details on prescription medication fills in the three months before the last menstrual period until 6 months after the estimated date of delivery. Necessitates additional... -
PRIDE Study medication diaries
6-week medication diaries covering prescription and over-the counter use, administered in the second trimester of pregnancy. Available for 1516 PRIDE Study participants... -
POM imaging data
Imaging data of the Personalized Parkinson Project, including structural and functional MRI. -
PRISMA Imaging data
The PRISMA imaging data consists of both processed and unprocessed screening mammograms (two views of each breast for each participant) obtained at study entry. -
PRIDE Study nutrition
Food frequency questionnaire administered in early pregnancy, assessing multiple macronutrients and micronutrients. -
PRIDE-BIOME project
Subproject among 116 PRIDE Study participants. Gut microbiome data for maternal samples collected at gestational weeks 20 and 34, and 2 months after the estimated date of... -
ReLife study quality of life questionnaire
The EORTC QLQ-C30 was completed at 3 (n=365), 12 (n=317) and 24 months (n=279) after surgery. -
The EuroTARGET cohort: A European project on TArgeted therapy in renal cell...
EuroTARGET is a European collaborative project designed as an observational study for which patients with mRCC were recruited prospectively in 62 centers. In total, 1,210...
Prístup do tohto zoznamu je možný aj cez API rozhranie API (viď. dokumentácia API Dokumenty API).